Possibilities of local therapy of mixed nonspecific bacterial-fungal vaginal infections

Introduction. The consequences of these mixed nonspecific vaginitis are manifested in the aggravation of the course of the disease, the complexity of diagnosis and the choice of therapy. Aim. Evaluation of the clinical and microbiological efficacy of a complex drug including clindamycin and butoconazole in local therapy of patients with mixed forms of nonspecific bacterial-fungal vaginal infections. Material and methods. 126 patients with a confirmed diagnosis of “mixed nonspecific bacterial-fungal vulvovaginitis”. The proposed therapy is a vaginal cream containing clindamycin phosphate and butoconazole nitrate (1 dose (5.0 g) for 6 days). Clinical and microbiological efficacy was assessed at 14 days (22 ± 3 days from the start of therapy – stage V2), 1 month (40 ± 3 days from the start of therapy – stage V3) and 3 months (100 ± 3 days from the start of therapy – stage V4) after the end of therapy. Results. Topical use of a drug containing an antibiotic (clindamycin phosphate) and an antimycotic (butoconazole nitrate) contributes to the leveling of clinical symptoms in the form of itching and dyspareunia, respectively, in 94.45% and 92.9%, pathological whites in 91.3% of women, normalization of the pH of vaginal secretions in 92.1% of patients. Microbiological efficacy at the end of the follow-up period was 88.1% (Hay/Ison Grade 1 and 2), 90.5% (Donders Grade <3) and 86.5% PCR. Conclusion. Clinical and microbiological evaluation of the use of containing an antibiotic (clindamycin phosphate) and an antimycotic (butoconazole nitrate) as a seven-day therapy, having a wide range of antibacterial and antimycotic activity with good tolerability, has shown high efficacy in the treatment of patients diagnosed with mixed nonspecific bacterial-fungal vulvovaginitis, which allows it to be recommended for the treatment of women with This nosology, and also offers a safe and effective option for empirical therapy of various vaginal infections.

Authors

Institutions

Publication Details

Journal
Meditsinskiy sovet = Medical Council
Published
2025-04-26
DOI
https://doi.org/10.21518/ms2025-152
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Possibilities of local therapy of mixed nonspecific bacterial-fungal vaginal infections

И. О. Боровиков, А. S. Magay, И. И. Куценко, O. I. Borovikova et al.
Meditsinskiy sovet = Medical Council
Reproductive tract infections research
article

Possibilities of local therapy of mixed nonspecific bacterial-fungal vaginal infections

И. О. Боровиков, А. S. Magay, И. И. Куценко, O. I. Borovikova, L. A. Filippova, A. V. Novikov
article en

Abstract

Introduction. The consequences of these mixed nonspecific vaginitis are manifested in the aggravation of the course of the disease, the complexity of diagnosis and the choice of therapy. Aim. Evaluation of the clinical and microbiological efficacy of a complex drug including clindamycin and butoconazole in local therapy of patients with mixed forms of nonspecific bacterial-fungal vaginal infections. Material and methods. 126 patients with a confirmed diagnosis of “mixed nonspecific bacterial-fungal vulvovaginitis”. The proposed therapy is a vaginal cream containing clindamycin phosphate and butoconazole nitrate (1 dose (5.0 g) for 6 days). Clinical and microbiological efficacy was assessed at 14 days (22 ± 3 days from the start of therapy – stage V2), 1 month (40 ± 3 days from the start of therapy – stage V3) and 3 months (100 ± 3 days from the start of therapy – stage V4) after the end of therapy. Results. Topical use of a drug containing an antibiotic (clindamycin phosphate) and an antimycotic (butoconazole nitrate) contributes to the leveling of clinical symptoms in the form of itching and dyspareunia, respectively, in 94.45% and 92.9%, pathological whites in 91.3% of women, normalization of the pH of vaginal secretions in 92.1% of patients. Microbiological efficacy at the end of the follow-up period was 88.1% (Hay/Ison Grade 1 and 2), 90.5% (Donders Grade <3) and 86.5% PCR. Conclusion. Clinical and microbiological evaluation of the use of containing an antibiotic (clindamycin phosphate) and an antimycotic (butoconazole nitrate) as a seven-day therapy, having a wide range of antibacterial and antimycotic activity with good tolerability, has shown high efficacy in the treatment of patients diagnosed with mixed nonspecific bacterial-fungal vulvovaginitis, which allows it to be recommended for the treatment of women with This nosology, and also offers a safe and effective option for empirical therapy of various vaginal infections.

Meditsinskiy sovet = Medical Council(4)
Kuban State Medical University (RU)
Openalex Percentile: Top 91%
Reproductive tract infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.